217 related articles for article (PubMed ID: 9242526)
1. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members.
Rathbun RK; Christianson TA; Faulkner GR; Jones G; Keeble W; O'Dwyer M; Bagby GC
Blood; 2000 Dec; 96(13):4204-11. PubMed ID: 11110692
[TBL] [Abstract][Full Text] [Related]
3. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily.
Koh PS; Hughes GC; Faulkner GR; Keeble WW; Bagby GC
Exp Hematol; 1999 Jan; 27(1):1-8. PubMed ID: 9923438
[TBL] [Abstract][Full Text] [Related]
4. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.
Pang Q; Fagerlie S; Christianson TA; Keeble W; Faulkner G; Diaz J; Rathbun RK; Bagby GC
Mol Cell Biol; 2000 Jul; 20(13):4724-35. PubMed ID: 10848598
[TBL] [Abstract][Full Text] [Related]
5. Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes.
Fagerlie SR; Diaz J; Christianson TA; McCartan K; Keeble W; Faulkner GR; Bagby GC
Blood; 2001 May; 97(10):3017-24. PubMed ID: 11342426
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.
Wang J; Otsuki T; Youssoufian H; Foe JL; Kim S; Devetten M; Yu J; Li Y; Dunn D; Liu JM
Cancer Res; 1998 Aug; 58(16):3538-41. PubMed ID: 9721856
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
8. In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC.
Kurre P; Anandakumar P; Grompe M; Kiem HP
Exp Hematol; 2002 Nov; 30(11):1257-62. PubMed ID: 12423678
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
[TBL] [Abstract][Full Text] [Related]
10. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
11. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.
Whitney MA; Royle G; Low MJ; Kelly MA; Axthelm MK; Reifsteck C; Olson S; Braun RE; Heinrich MC; Rathbun RK; Bagby GC; Grompe M
Blood; 1996 Jul; 88(1):49-58. PubMed ID: 8704201
[TBL] [Abstract][Full Text] [Related]
12. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice.
Haneline LS; Broxmeyer HE; Cooper S; Hangoc G; Carreau M; Buchwald M; Clapp DW
Blood; 1998 Jun; 91(11):4092-8. PubMed ID: 9596654
[TBL] [Abstract][Full Text] [Related]
13. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.
Pang Q; Keeble W; Diaz J; Christianson TA; Fagerlie S; Rathbun K; Faulkner GR; O'Dwyer M; Bagby GC
Blood; 2001 Mar; 97(6):1644-52. PubMed ID: 11238103
[TBL] [Abstract][Full Text] [Related]
14. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
15. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
Sato T; Selleri C; Young NS; Maciejewski JP
Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
[TBL] [Abstract][Full Text] [Related]
18. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells.
Pearl-Yafe M; Halperin D; Halevy A; Kalir H; Bielorai B; Fabian I
Biochem Pharmacol; 2003 Mar; 65(5):833-42. PubMed ID: 12628494
[TBL] [Abstract][Full Text] [Related]
19. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD
Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804
[TBL] [Abstract][Full Text] [Related]
20. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]